Drug
Sovaprevir
Sovaprevir: highest development phase Phase 2, developed by Alexion. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Alexion
Trials
| Drug | Phase | Indication |
|---|---|---|
| Sovaprevir NCT01849562 | Phase 2 | Hepatitis C, Chronic |
Latest
No recent events.
Follow Sovaprevir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.